Market Overview

UPDATE: Stifel Nicolaus Initiates IDEXX Laboratories at Hold on Valuation, Market Share Risk

Share:
Related IDXX
Stocks Hitting 52-Week Highs
12 Contrarian Plays For The Bears

Stifel Nicolaus initiated coverage on IDEXX Laboratories (NASDAQ: IDXX) with a Hold rating.

Stifel Nicolaus commented, "IDEXX's dominance in what has proven to be a relatively resilient vet market is likely to continue. That said, we believe this is already reflected in the stock's premium valuation. In addition, our work uncovers some headwinds that may strengthen as we enter 2013, notably, future chemistry share losses and an unfavorable change in the distributor landscape."

IDEXX Laboratories closed at $93.89 on Wednesday.

Latest Ratings for IDXX

DateFirmActionFromTo
Apr 2016Credit SuisseMaintainsOutperform
Apr 2016CL KingInitiates Coverage onNeutral
Mar 2016Stifel NicolausMaintainsBuy

View More Analyst Ratings for IDXX
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (IDXX)

View Comments and Join the Discussion!